PMEF
NUVB icon

Point72 Middle East FZE’s Nuvation Bio NUVB Stock Holding History

Point72 Middle East FZE’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30,732
Closed -$46.4K – 919
2023
Q4 		$46.4K Buy
30,732
+4,445
+17% +$5.72K ﹤0.01% 1293
2023
Q3 		$35.2K Buy
+26,287
New +$43.8K ﹤0.01% 1267
2023
Q1 		– Sell
-3,133
Closed -$6.01K – 2035
2022
Q4 		$6.01K Buy
+3,133
New +$6.34K ﹤0.01% 1766

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Middle East FZE's NUVB Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Nuvation Bio (NUVB) in Q1 2024, closing a stake of 30,732 shares — an estimated $46.4K sold.

Point72 Middle East FZE first reported a position in NUVB in Q4 2022 and held it in 3 quarters. The position peaked at $46.4K in Q4 2023. 124 funds tracked by Wall St. Rank hold NUVB as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Nuvation Bio position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 30,732 Nuvation Bio shares in Q1 2024, an estimated $46.4K.
  • Point72 Middle East FZE first reported a position in Nuvation Bio in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Nuvation Bio position peaked at $46.4K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.